Phys Vivas · haematological
Haemolytic Anaemia — Viva Defence
DCE viva defence for Haemolytic Anaemia.
On this page
Study tools
Target exams
Haemolytic Anaemia Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Haemolytic Anaemia. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
References3ShowHide
- [1]Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting Blood Rev, 2020.PMID 31839434
- [2]Bolton-Maggs PH, Langer JC, Iolascon A, Tittensor P, King MJ Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update Br J Haematol, 2012.PMID 22055020
- [3]Youngster I, Arcavi L, Schechmaster R, et al. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review Drug Saf, 2010.PMID 20701405